- VERU -2.92%
Search results
- 1.3300Add to watchlist-0.0400 (-2.92%)At close: Fri. May 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open1.3800High1.4500Low1.3300
- Mkt Cap194.69MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.370052 Wk. Low0.360052 Wk. High1.9200
Top storiesVeru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial RecoveryYahoo Finance · 2 days ago- VERU -2.92%
Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial StrainsYahoo Finance · 3 days ago- VERU -2.92%
Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?Yahoo Finance · 2 weeks agoRelated stocks
Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Conversations
Find the latest Veru Inc. (VERU) stock discussion in Yahoo...
- Latest Stock News & Headlines
Explore key insights from Veru Inc's Q2 2024 earnings,...
- Statistics
Find out all the key statistics for Veru Inc. (VERU),...
- Conversations
3 days ago · Veru stock price target raised to $19 from $9 at Oppenheimer Dec. 16, 2020 at 8:13 a.m. ET by Tomi Kilgore Veru's stock soars again on heavy volume after positive results of breast cancer treatment
Get the latest Veru Inc (VERU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Explore key insights from Veru Inc's Q2 2024 earnings, emphasizing improved financial management and strategic advancements in pharmaceutical development. --Phase 2b clinical study of enobosarm in ...
People also ask
What are Veru share price targets?
Who founded Veru Inc?
Where can I buy Veru stock?
Should investors buy Veru (Veru) shares?
Discover real-time Veru Inc. Common Stock (VERU) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
View the latest Veru Inc. (VERU) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Veru to Present at the GLP-1 Based Therapeutics Summit. MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that the Company has been invited to give a ...